Trexquant Investment LP

Position in BEAM — Beam Therapeutics Inc.

CIK 1633445 STAMFORD, CT

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$528,733

-$88,671 QoQ

Shares Held

15,406

-39.4% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#139

of 274 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. BEAM ranks #126 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$528,733	15,406	-39.4%	Shares	Sole	2026-08-14
2025-09-30	$617,404	25,439	-82.9%	Shares	Sole	2025-11-14
2025-06-30	$2,535,374	149,052	+896.9%	Shares	Sole	2025-08-12
2023-09-30	$359,595	14,952	+83.1%	Shares	Sole	2023-11-13
2023-03-31	$249,981	8,164	+58.9%	Shares	Sole	2023-05-15
2022-12-31	$200,986	5,139	-76.9%	Shares	Sole	2023-02-13
2022-09-30	$1,059,227	22,234	-61.5%	Shares	Sole	2022-11-14
2022-06-30	$2,232,676	57,677	+166.7%	Shares	Sole	2022-08-11
2022-03-31	$1,239,227	21,627	+56.7%	Shares	Sole	2022-05-13
2021-09-30	$1,200,999	13,803	+110.9%	Shares	Sole	2021-11-12
2021-06-30	$842,278	6,544	-63.4%	Shares	Sole	2021-08-12
2021-03-31	$1,430,955	17,878	+106.2%	Shares	Sole	2021-05-13
2020-12-31	$707,737	8,669	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.